1
|
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.
|
Neurobiol Aging
|
2007
|
1.61
|
2
|
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.
|
J Alzheimers Dis
|
2007
|
1.54
|
3
|
Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study.
|
J Neurol Neurosurg Psychiatry
|
2009
|
1.15
|
4
|
Cognitive profiles of incipient dementia in the Goteborg MCI study.
|
Dement Geriatr Cogn Disord
|
2010
|
1.02
|
5
|
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
|
J Alzheimers Dis
|
2012
|
0.99
|
6
|
Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
|
J Int Neuropsychol Soc
|
2008
|
0.92
|
7
|
Cognitive profiles of mild cognitive impairment with and without vascular disease.
|
Neuropsychology
|
2007
|
0.88
|
8
|
Subcortical vascular dementia biomarker pattern in mild cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2009
|
0.88
|
9
|
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.
|
J Clin Psychiatry
|
2006
|
0.88
|
10
|
Sahlgrenska Academy Self-reported Cognitive Impairment Questionnaire (SASCI-Q)--a research tool discriminating between subjectively cognitively impaired patients and healthy controls.
|
Int Psychogeriatr
|
2012
|
0.82
|
11
|
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.
|
J Cereb Blood Flow Metab
|
2016
|
0.81
|
12
|
High Prevalence of Stress and Low Prevalence of Alzheimer Disease CSF Biomarkers in a Clinical Sample with Subjective Cognitive Impairment.
|
Dement Geriatr Cogn Disord
|
2016
|
0.79
|
13
|
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.
|
Dement Geriatr Cogn Disord
|
2012
|
0.78
|
14
|
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment.
|
J Neural Transm (Vienna)
|
2012
|
0.78
|
15
|
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.
|
J Cereb Blood Flow Metab
|
2016
|
0.76
|
16
|
Prognostic Accuracy of Mild Cognitive Impairment Subtypes at Different Cut-Off Levels.
|
Dement Geriatr Cogn Disord
|
2017
|
0.75
|